Structure Therapeutics Inc. (GPCR)

NASDAQ: GPCR · Real-Time Price · USD

57.73

-1.97 (-3.30%)

At close: Mar 6, 2026, 4:00 PM EST

58.28

+0.55 (0.95%)

After-hours: Mar 6, 2026, 6:49 PM EST

Structure Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	61.55	49.41	32.67	16.37	8.59
Research & Development	225.26	108.81	70.1	36.19	29.11
Other Operating Expenses	-100	-	-	-	-
Operating Expenses	186.81	158.23	102.78	52.56	37.7
Operating Income	-186.81	-158.23	-102.78	-52.56	-37.7
Interest Expense	-	-	-	-	-0.12
Interest & Investment Income	35.87	36.01	13.39	1.26	-
EBT Excluding Unusual Items	-150.94	-122.22	-89.38	-51.3	-37.82
Gain (Loss) on Sale of Assets	10.25	-	-	-	-
Pretax Income	-140.69	-122.22	-89.38	-51.3	-37.82
Income Tax Expense	0.52	0.31	0.24	0.02	0.23
Net Income	-141.2	-122.53	-89.62	-51.32	-38.05
Preferred Dividends & Other Adjustments	-	-	-	1.52	5.72
Net Income to Common	-141.2	-122.53	-89.62	-52.84	-43.77
Shares Outstanding (Basic)	59	53	37	3	3
Shares Outstanding (Diluted)	59	53	37	3	3
Shares Change (YoY)	12.46%	43.31%	1049.81%	17.72%	30.01%
EPS (Basic)	-2.39	-2.33	-2.44	-16.54	-16.13
EPS (Diluted)	-2.39	-2.33	-2.44	-16.54	-16.13
Free Cash Flow	-225.81	-117.93	-81.66	-46.28	-33.37
Free Cash Flow Per Share	-3.81	-2.24	-2.22	-14.48	-12.30
EBITDA	-185.13	-157.23	-102.46	-52.28	-37.62
D&A For EBITDA	1.68	1	0.32	0.28	0.07
EBIT	-186.81	-158.23	-102.78	-52.56	-37.7

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q